Literature DB >> 11886432

Nature of nontransferrin-bound iron.

Robert C Hider1.   

Abstract

Nontransferrin-bound iron is now recognized to exist by many workers. It is present in the serum of patients suffering from a wide range of disease states and may be induced by certain therapeutic treatments. The chemical nature of this iron pool is unknown but almost certainly it is a multicomponent pool including a considerable proportion of protein-bound iron. Methods are required to separate and quantify these different components. The biological properties of the individual isoforms need to be established; it is possible that some forms are relatively nontoxic, while others are highly toxic. This paper reviews what is known about the nature of nontransferrin-bound iron and describes the methods currently available to quantify this important serum component.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11886432     DOI: 10.1046/j.1365-2362.2002.0320s1050.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  32 in total

1.  Non-alcoholic fatty liver disease: is iron relevant?

Authors:  Julia O'Brien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2011-08-12       Impact factor: 6.047

2.  Biophysical investigation of the ironome of human jurkat cells and mitochondria.

Authors:  Nema D Jhurry; Mrinmoy Chakrabarti; Sean P McCormick; Gregory P Holmes-Hampton; Paul A Lindahl
Journal:  Biochemistry       Date:  2012-06-22       Impact factor: 3.162

3.  Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders.

Authors:  Louise de Swart; Jan C M Hendriks; Lisa N van der Vorm; Z Ioav Cabantchik; Patricia J Evans; Eldad A Hod; Gary M Brittenham; Yael Furman; Boguslaw Wojczyk; Mirian C H Janssen; John B Porter; Vera E J M Mattijssen; Bart J Biemond; Marius A MacKenzie; Raffaella Origa; Renzo Galanello; Robert C Hider; Dorine W Swinkels
Journal:  Haematologica       Date:  2015-09-18       Impact factor: 9.941

Review 4.  Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.

Authors:  K Oettl; R E Stauber
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

5.  Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation.

Authors:  Eldad A Hod; Ning Zhang; Set A Sokol; Boguslaw S Wojczyk; Richard O Francis; Daniel Ansaldi; Kevin P Francis; Phyllis Della-Latta; Susan Whittier; Sujit Sheth; Jeanne E Hendrickson; James C Zimring; Gary M Brittenham; Steven L Spitalnik
Journal:  Blood       Date:  2010-03-18       Impact factor: 22.113

6.  Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone.

Authors:  Patricia Evans; Reem Kayyali; Robert C Hider; John Eccleston; John B Porter
Journal:  Transl Res       Date:  2010-05-27       Impact factor: 7.012

7.  Relationship between free iron and glycated hemoglobin in uncontrolled type 2 diabetes patients associated with complications.

Authors:  Jeevan K Shetty; Mungli Prakash; Mohammad S Ibrahim
Journal:  Indian J Clin Biochem       Date:  2008-03-06

8.  Stored blood: how old is too old?

Authors:  Janet S Lee; Daniel B Kim-Shapiro
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

9.  The role of endocytic pathways in cellular uptake of plasma non-transferrin iron.

Authors:  Yang-Sung Sohn; Hussam Ghoti; William Breuer; Eliezer Rachmilewitz; Samah Attar; Guenter Weiss; Z Ioav Cabantchik
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

10.  Prolonged red cell storage before transfusion increases extravascular hemolysis.

Authors:  Francesca Rapido; Gary M Brittenham; Sheila Bandyopadhyay; Francesca La Carpia; Camilla L'Acqua; Donald J McMahon; Abdelhadi Rebbaa; Boguslaw S Wojczyk; Jane Netterwald; Hangli Wang; Joseph Schwartz; Andrew Eisenberger; Mark Soffing; Randy Yeh; Chaitanya Divgi; Yelena Z Ginzburg; Beth H Shaz; Sujit Sheth; Richard O Francis; Steven L Spitalnik; Eldad A Hod
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.